Biomarkers are increasingly becoming the focus of drug development processes. Pharmaceutical companies are looking to increase R&D productivity and reduce errors by using biomarkers early in the development process. In the following article, we present several uses for, as well as limitations of, biomarkers in the drug R&D process.
I was skeptical coming into this engagement, but have been impressed by the process. No doubt enhanced by the quality of the team! I think that a lot of key issues came to light.Advisory Board Participant